Independent · Evidence-led · We don't sell peptides
EU / NordicsUpdated weeklyEN

Blog

Daily evidence-led peptide research, regulatory news, expert digest and explainers. Every claim sourced; no AI tells.

Page 92

Expert digest

Tesamorelin: what experts said, Q2 2026

Tesamorelin has one FDA approval and plenty of off-label hype. Here is what named experts said this quarter.

15 Jun 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

Boerhaave syndrome after semaglutide use

A 2026 case report describes the first documented esophageal perforation linked to GLP-1 agonist-induced vomiting after skipping dose titration.

14 Jun 2026 · PeptideMethods Editorial Team · 4 min read
Expert digest

What experts said about BPC-157 in Q2 2026

A digest of on-record expert commentary on BPC-157 from Q2 2026, with credentials, conflicts of interest, and the evidence gaps each expert flagged.

14 Jun 2026 · PeptideMethods Editorial Team · 5 min read
Expert digest

What experts said about CJC-1295 in Q2 2026

On-record expert commentary on CJC-1295 from Q2 2026: the evidence gap, cancer-risk concerns, regulatory shifts, and the upcoming PCAC review.

14 Jun 2026 · PeptideMethods Editorial Team · 4 min read
Expert digest

Ipamorelin: what experts said, Q2 2026

On-record expert commentary on ipamorelin from Q2 2026, with credentials, conflicts of interest, and the FDA regulatory picture.

14 Jun 2026 · PeptideMethods Editorial Team · 5 min read
Explainer

Oral semaglutide for weight loss, reviewed

A Postgraduate Medicine review examines the trial evidence, dosing requirements, and practical considerations for using oral semaglutide in weight management.

14 Jun 2026 · PeptideMethods Editorial Team · 5 min read
Explainer

Peptides for nerve recovery after surgery

BPC-157, TB-500, and ARA 290 are discussed in recovery communities after nerve surgery. Here is what preclinical and early clinical evidence actually shows.

14 Jun 2026 · PeptideMethods Editorial Team · 5 min read
Expert digest

What experts said about PT-141 in Q2 2026

On-record expert commentary on PT-141 from Q2 2026: arguments for male trials, a Harvard meta-analysis, and Palatin's obesity pivot.

14 Jun 2026 · PeptideMethods Editorial Team · 5 min read
Explainer

Why your Semax or Selank spray smells off

A fishy or sulfurous smell from a pre-mixed peptide nasal spray usually signals degradation. The methionine chemistry explains why.

14 Jun 2026 · PeptideMethods Editorial Team · 5 min read
Explainer

Switching Peptides: What the Evidence Says

No clinical guideline covers switching between incretin-class peptides. Prescribing information and early research both say: start at the lowest dose.

14 Jun 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

BPC-157 tested as AChE inhibitor in vitro

A 2026 lab study finds BPC-157 and two hybrid peptides inhibit the enzyme targeted by Alzheimer's drugs, but at low potency and only in vitro.

13 Jun 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

Which drugs flag for gastric motility risks

A 2026 study screened 58 million adverse-event reports. Semaglutide had the strongest signal for impaired gastric emptying.

13 Jun 2026 · PeptideMethods Editorial Team · 4 min read